ArticleCell reports. Medicine2024

Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.

Koji Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.